» Articles » PMID: 25217834

Shedding of Dipeptidyl Peptidase 4 is Mediated by Metalloproteases and Up-regulated by Hypoxia in Human Adipocytes and Smooth Muscle Cells

Overview
Journal FEBS Lett
Specialty Biochemistry
Date 2014 Sep 15
PMID 25217834
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

Dipeptidyl peptidase 4 is an important drug target for diabetes and a novel adipokine. However, it is unknown how soluble DPP4 (sDPP4) is cleaved from the cell membrane and released into the circulation. We show here that MMP1, MMP2 and MMP14 are involved in DPP4 shedding from human vascular smooth muscle cells (SMC) and MMP9 from adipocytes. Hypoxia increased DPP4 shedding from SMC which is associated with increased mRNA expression of MMP1. Our data suggest that constitutive as well as hypoxia-induced DPP4 shedding occurs due to a complex interplay between different MMPs in cell type-specific manner.

Citing Articles

Higher Serum Dipeptidyl Peptidase-4 Activity in Newly Diagnosed Young-Onset Type 2 Diabetes Mellitus.

Mahmood T, Rahman H, Jahan S, Sultana N, Hasan M, Hasan M Cureus. 2024; 16(10):e70968.

PMID: 39507187 PMC: 11538487. DOI: 10.7759/cureus.70968.


Elucidation of DPP-4 involvement in systemic distribution and renal reabsorption of linagliptin by PBPK modeling with a cluster Gauss-Newton method.

Nakamura R, Yoshikado T, Aoki Y, Sugiyama Y, Chiba K Clin Transl Sci. 2024; 17(10):e70047.

PMID: 39435882 PMC: 11494486. DOI: 10.1111/cts.70047.


The multiple actions of dipeptidyl peptidase 4 (DPP-4) and its pharmacological inhibition on bone metabolism: a review.

Pechmann L, Pinheiro F, Andrade V, Moreira C Diabetol Metab Syndr. 2024; 16(1):175.

PMID: 39054499 PMC: 11270814. DOI: 10.1186/s13098-024-01412-x.


Soluble CD26: From Suggested Biomarker for Cancer Diagnosis to Plausible Marker for Dynamic Monitoring of Immunotherapy.

Kotrulev M, Gomez-Tourino I, Cordero O Cancers (Basel). 2024; 16(13).

PMID: 39001488 PMC: 11240764. DOI: 10.3390/cancers16132427.


Dipeptidyl-peptidase 4 (DPP4) mediates fatty acid uptake inhibition by glucose via TAS1R3 and GLUT-2 in Caco-2 enterocytes.

Preinfalk V, Kimmeswenger I, Somoza V, Lieder B Heliyon. 2024; 10(9):e30329.

PMID: 38707340 PMC: 11066672. DOI: 10.1016/j.heliyon.2024.e30329.